BioCryst Pharmaceuticals, Inc. (BCRX)

USD 7.31

(-2.4%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 516.96 Million 550 Million 588.15 Million 334.71 Million 175.28 Million 146.84 Million
Total Current Assets 495.96 Million 516.5 Million 566.13 Million 323.8 Million 164.34 Million 114.35 Million
Cash And Short Term Investments 390.79 Million 442.38 Million 514.43 Million 300.36 Million 136.22 Million 126.84 Million
Cash and Cash Equivalents 112.44 Million 304.76 Million 504.38 Million 272.12 Million 114.17 Million 26.73 Million
Short Term Investments 278.34 Million 119.54 Million 3.21 Million 28.23 Million 22.05 Million 77.73 Million
Net Receivables 56.95 Million 50.59 Million 29.41 Million 8.64 Million 22.14 Million 4.29 Million
Inventory 28.68 Million 27.53 Million 15.79 Million 7.03 Million 1.55 Million 1.64 Million
Other Current Assets 19.54 Million 12.58 Million 9.98 Million 5.52 Million 4.42 Million 2.39 Million
Total Non-Current Assets 20.99 Million 33.5 Million 22.01 Million 10.91 Million 10.93 Million 32.48 Million
Net PPE 20.99 Million 15.42 Million 8.71 Million 7.11 Million 7.34 Million 9.13 Million
Good Will And Intangible Assets - - - - - -
Good Will - - - - - -
Intangible Assets - - - - - -
Long-Term Investments - 18.07 Million 6.82 Million - - 22.37 Million
Tax Assets - - - - - -
Other Non Current Assets - -33.5 Million 6.47 Million 3.8 Million 3.59 Million 978 Thousand
Other Assets - - - - - -
Total Liabilities 972.48 Million 844.59 Million 695.13 Million 353.97 Million 137.03 Million 97.6 Million
Total Current Liabilities 149.98 Million 105.51 Million 103.71 Million 105.65 Million 92.33 Million 69.47 Million
Account Payables 20.89 Million 14.35 Million 27.8 Million 18.71 Million 13.98 Million 7.76 Million
Tax Payables - 410 Thousand 2.62 Million 80 Thousand 67 Thousand 51 Thousand
Short Term Debt 26.21 Million 2.36 Million 1.81 Million 31.17 Million 39.95 Million 33.74 Million
Deferred Revenue - 1.22 Million 1.42 Million 150 Thousand 2.12 Million 221 Thousand
Other Current Liabilities 102.88 Million 87.56 Million 72.67 Million 55.61 Million 36.26 Million 27.73 Million
Total Non Current Liabilities 822.5 Million 739.08 Million 591.41 Million 248.32 Million 44.69 Million 28.12 Million
Long-Term Debt 811.26 Million 739.08 Million 591.41 Million 124.71 Million 44.69 Million 28.07 Million
Deferred Revenue Non Current - - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 11.23 Million - - 123.6 Million - 54 Thousand
Other Liabilities - - - - - -
Total Equity -455.52 Million -1.45 Billion -1.2 Billion -1.02 Billion -840.62 Million -731.96 Million
Stock Holders Equity -455.52 Million -1.45 Billion -1.2 Billion -1.02 Billion -840.62 Million -731.96 Million
Common Stock 2.05 Million 1.87 Million 1.84 Million 1.76 Million 1.54 Million 1.1 Million
Retained Earnings -1.68 Billion -1.45 Billion -1.2 Billion -1.02 Billion -840.62 Million -731.96 Million
Accumulated other comprehensive income 1.33 Million 26 Thousand 177 Thousand 3000.00 39 Thousand -297 Thousand
Common Stock Equity -455.52 Million -1.45 Billion -1.2 Billion -1.02 Billion -840.62 Million -731.96 Million
Capital Lease Obligation 11.23 Million 8.17 Million 7.78 Million 124.71 Million 4.78 Million 2.75 Million
Total Investments 278.34 Million 137.62 Million 10.04 Million 28.23 Million 22.05 Million 100.11 Million
Total Debt 848.71 Million 741.45 Million 593.23 Million 124.71 Million 84.65 Million 61.82 Million
Net Debt 736.26 Million 436.68 Million 88.84 Million -147.41 Million -29.51 Million 35.09 Million

Balance Sheet Charts